[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337971-105":59,"doc-detail-337971-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","an-immune-biomarker-associated-with-emt-serves-as-a-predictor-for-prognosis-and-drug-response-in-bladder-cancer","An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer","","Bladder cancer (BLCA) remains a leading urinary tract malignancy with limited reliable biomarkers for predicting onset, progression, and patient outcomes. The study investigates WDHD1, a gene influencing signaling, the cell cycle, and cellular structure, and clarifies its role in BLCA immune biology, prognosis, EMT processes, immune infiltration, and drug sensitivity. Using WGCNA plus bioinformatics and experimental validation, a 32-gene risk model was built, with high WDHD1 linked to poorer survival and immunologic associations. High WDHD1 expression also predicted sensitivity to four broad-spectrum anticancer drugs.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-immune-biomarker-associated-with-emt-serves-as-a-predictor-for-prognosis-and-drug-response-in-bladder-cancer/337971/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-immune-biomarker-associated-with-emt-serves-as-a-predictor-for-prognosis-and-drug-response-in-bladder-cancer/337971.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main aim of the study?","Question",{"text":112,"@type":113},"To determine whether WDHD1, an immune-related biomarker linked with EMT, can predict prognosis and drug response in bladder cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was WDHD1 evaluated in relation to bladder cancer?",{"text":117,"@type":113},"The research used WGCNA with TCGA/GEO data, followed by bioinformatic analyses and experimental validation to connect WDHD1 with expression patterns, clinical traits, immune infiltration, EMT, and drug sensitivity.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about WDHD1 expression?",{"text":121,"@type":113},"Higher WDHD1 expression was associated with a 32-gene risk model and predicted worse survival, along with broad associations across immunology and immune-related features.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337971,1790179944,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 13  \nResearch Paper  \nAn immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer  \nYike Jiang1,2,*, Zichuan Yu2,*, Hao Zheng2,*, Xuanrui Zhou2, Minqin Zhou2, Xitong Geng2, Yanting Zhu2, Shuhan Huang2, Yiyang Gong2, Liangyun Guo1  \n1 Department of Ultrasonography, Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, China  \n2Second College of Clinical Medicine, Nanchang University, Nanchang, Jiangxi 330000, China  \n* Equal contribution  \nCorrespondence to: Liangyun Guo; email: [guoliangyun0917@163.com](guoliangyun0917@163.com), [https://orcid.org/0000-0001-9122-2976](https://orcid.org/0000-0001-9122-2976)[ ](https://orcid.org/0000-0001-9122-2976)[Keywords:](Keywords: bladder cancer)[ bladder cancer](Keywords: bladder cancer), WDHD1, immune cell infiltration, EMT, single-cell sequencing, biomarker  \nReceived: December 5, 2023 Accepted: April 22, 2024 Published: July 8, 2024  \nCopyright: © 2024 Jiang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nBackground: Bladder cancer (BLCA), which develops from the upper endometrial of the bladder, is the sixth most prevalent cancer across the globe. WDHD1 (WD repeat and HMG-box DNA binding protein 1 gene) directly affects signaling, the cell cycle, and the development of the cell skeleton. Uncertainty surrounds WDHD1's function in BLCA immunity and prognosis, though.  \nMaterials and Methods: Using weighed gene co-expression network analysis (WGCNA), initially, we first identified 32 risk factors in genes with differential expression for this investigation. Then, using a variety of bioinformatic techniques and experimental validation, we examined the connections between WDHD1 and BLCA expression, clinical pathological traits, WDHD1-related proteins, upper-skin-intermediate conversion (EMT), immune cell immersion, convergence factors, immune markers, and drug sensitivity.  \nResult: The findings demonstrated that we constructed a 32-gene risk-predicting model where WDHD1 was elevated as a representative gene expression in BLCA and related to a range of clinical traits. Furthermore, high WDHD1 expression was a standalone predictor associated with a worse survival rate. The most commonly recruited cells and their evolutionary patterns were highlighted to better comprehend WDHD1's function in cancer. High WDHD1 expression was associated with many aspects of immunology. Finally, the study found that individuals with high expression of WDHD1 were drug-sensitive to four different broad-spectrum anticancer drugs.  \nConclusion: These results describe dynamic changes in the tumor microenvironment in BLCA and provide evidence for the hypothesis that WDHD1 is a novel biomarker of tumor development. WDHD1 may therefore be a useful target for the detection and management of BLCA.  \nINTRODUCTION  \nBladder cancer (BLCA) stands as the most prevalent malignancy of the urinary tract and ranks among the world’s top ten cancers. It is categorized into two primary types: muscle-invasive bladder cancers (MIBC) and non-muscle-invasive bladder cancers (NMIBC) [1] .  \nHowever, even among patients getting the greatest surgery and chemotherapy, 50–70% of NMIBC patients still experience recurrence and transfer, and 10–20% continue to advance to MIBC [2, 3], resulting in a mere 23–48% overall survival percentage after 5 years. Owing to the aggressiveness and unpredictability of the disease, clinical results for BLCA patients have not  \n10813  \nmuch improved over the past two decades, despite improvements in surgical technology and postoperative care [4] . However, there are still few trustworthy tumor markers that can precisely forecast the emergence and development o","cbCaiqhLHHMxK6Mk","https://ap.wps.com/l/cbCaiqhLHHMxK6Mk","pdf",3316184,"English","# Abstract\n# Introduction\n## Bladder cancer background\n## Tumor microenvironment and EMT\n## Rationale for WDHD1","[{\"question\":\"What is the main aim of the study?\",\"answer\":\"To determine whether WDHD1, an immune-related biomarker linked with EMT, can predict prognosis and drug response in bladder cancer.\"},{\"question\":\"How was WDHD1 evaluated in relation to bladder cancer?\",\"answer\":\"The research used WGCNA with TCGA/GEO data, followed by bioinformatic analyses and experimental validation to connect WDHD1 with expression patterns, clinical traits, immune infiltration, EMT, and drug sensitivity.\"},{\"question\":\"What did the results show about WDHD1 expression?\",\"answer\":\"Higher WDHD1 expression was associated with a 32-gene risk model and predicted worse survival, along with broad associations across immunology and immune-related features.\"}]","An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer | PDF",1790021386,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab3864ad8b1189b6eacd812a906df352.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e4e538cf461fa14a6997955d8ce2af6.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10d5b564ee7ff77b781fd0ed4a73abdc.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb5905ec69cd9c682bf70450dabfb971.webp",980,1268]